Mobara, Japan

Tsutomu Katakami


Average Co-Inventor Count = 6.0

ph-index = 4

Forward Citations = 56(Granted Patents)


Location History:

  • Kanagawa, JP (1985)
  • Yokohama, JP (1985 - 1990)
  • Kamakura, JP (1991)
  • Mobara, JP (1992 - 1994)

Company Filing History:


Years Active: 1985-1994

Loading Chart...
10 patents (USPTO):Explore Patents

Title: Tsutomu Katakami: Innovator in Cardiac Treatment

Introduction

Tsutomu Katakami is a prominent inventor based in Mobara, Japan. He has made significant contributions to the field of medical treatment, particularly in the development of antiarrhythmic agents. With a total of 10 patents to his name, Katakami's work has had a substantial impact on cardiac health.

Latest Patents

Among his latest patents are pyrimidinedione derivatives that serve as antiarrhythmic agents. These compounds feature a unique structure where a phenyl group is linked to a pyrimidinedione part through an alkyl chain and a heterocyclic ring containing nitrogen atoms. This innovative design allows for effective treatment of cardiac arrhythmias. The pyrimidinedione derivatives are characterized by their basic backbone and various substituents, making them versatile in medical applications.

Career Highlights

Throughout his career, Tsutomu Katakami has worked with notable companies such as Mitsui Toatsu Chemicals, Incorporated and Mitsui Toatsu Kagaku Kabushiki Kaisha. His experience in these organizations has contributed to his expertise in the field of chemical compounds and their medical applications.

Collaborations

Some of his notable coworkers include Joji Kamiya and Nobuyuki Fukazawa. Their collaboration has likely fostered innovation and advancement in their shared field of research.

Conclusion

Tsutomu Katakami's contributions to the development of antiarrhythmic agents highlight his role as a key innovator in cardiac treatment. His patents and collaborations reflect a commitment to improving medical outcomes for patients with cardiac arrhythmias.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…